tiprankstipranks
CV Sciences Inc (GB:0HRT)
LSE:0HRT

CV Sciences (0HRT) Share Price & Analysis

0 Followers

0HRT Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$0.03 - $0.05
Previous Close$0.03
Volume0.00
Average Volume (3M)4.12K
Market Cap
$6.19M
Enterprise Value$4.72M
Total Cash (Recent Filing)$1.64M
Total Debt (Recent Filing)$219.00K
Price to Earnings (P/E)N/A
Beta0.88
May 09, 2024
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding163,228,469
10 Day Avg. Volume1,519
30 Day Avg. Volume4,117
Standard Deviation0.18
R-Squared0.07
Alpha-0.07
Financial Highlights & Ratios
Price to Book (P/B)2.01
Price to Sales (P/S)13.70
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue0.29
Enterprise Value/Gross Profit0.85
Enterprise Value/Ebitda1.72
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0

Financials

Annual

Options Prices

Currently, No data available
---

Ownership Overview

0.00%0.00%<0.01%100.00%
0.00%
Insiders
0.00%
Mutual Funds
<0.01% Other Institutional Investors
100.00% Public Companies and
Individual Investors

0HRT FAQ

What was CV Sciences Inc’s price range in the past 12 months?
CV Sciences Inc lowest share price was $0.03 and its highest was $0.04 in the past 12 months.
    What is CV Sciences Inc’s market cap?
    Currently, no data Available
    When is CV Sciences Inc’s upcoming earnings report date?
    CV Sciences Inc’s upcoming earnings report date is May 09, 2024 which is in 12 days.
      How were CV Sciences Inc’s earnings last quarter?
      CV Sciences Inc released its earnings results on Mar 28, 2024. The company reported -$0.005 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.005.
        Is CV Sciences Inc overvalued?
        According to Wall Street analysts CV Sciences Inc’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does CV Sciences Inc pay dividends?
          CV Sciences Inc does not currently pay dividends.
          What is CV Sciences Inc’s EPS estimate?
          CV Sciences Inc’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does CV Sciences Inc have?
          Currently, no data Available
          What happened to CV Sciences Inc’s price movement after its last earnings report?
          CV Sciences Inc reported an EPS of -$0.005 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
            Which hedge fund is a major shareholder of CV Sciences Inc?
            Currently, no hedge funds are holding shares in GB:0HRT
            ---

            CV Sciences Stock Smart Score

            N/A
            Not Ranked
            1
            2
            3
            4
            5
            6
            7
            8
            9
            10

            Technicals

            SMA
            Positive
            20 days / 200 days
            Momentum
            -17.77%
            12-Months-Change

            Fundamentals

            Return on Equity
            291.82%
            Trailing 12-Months
            Asset Growth
            -14.04%
            Trailing 12-Months

            Company Description

            CV Sciences Inc

            CV Sciences, Inc. engages in the development, manufacture, and sale of consumer and pharmaceutical products. It operates through the Consumer Products and Specialty Pharmaceutical segments. The Consumer Products segment includes manufacturing, marketing, and selling of hemp-based cannabidiol products through the PlusCBD brand. The Specialty Pharmaceutical segment focuses on developing cannabinoids to treat medical indications. The company was founded by H. J. Cole, Michael J. Mona, Jr. and Michael J. Mona III on December 9, 2010 and is headquartered in San Diego, California.
            ---

            0HRT Earnings Call

            Q4 2024
            0:00 / 0:00
            ---
            Similar Stocks
            Company
            Price & Change
            Follow
            CV Sciences
            Cannabis Sativa
            Hemp
            Corbus Pharmaceuticals
            Popular Stocks
            ---
            What's Included in PREMIUM?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis